Reducing Drug-Related Mortality Using Predictive Analytics: A Randomized, Statewide, Community Intervention Trial

使用预测分析降低药物相关死亡率:一项随机、全州范围的社区干预试验

基本信息

  • 批准号:
    10173211
  • 负责人:
  • 金额:
    $ 16.85万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-09-30 至 2024-07-31
  • 项目状态:
    已结题

项目摘要

The COVID-19 pandemic is colliding with the ongoing drug overdose epidemic, a public health crisis that has taken over 750,000 lives in the United States over the past two decades. The pandemic and associated policy responses will have lasting impacts of the lives of people at risk for overdose. Moreover, the immediate effects of the pandemic on access to overdose prevention and treatment resources, as well as fatal and nonfatal overdose rates, are in need of urgent study. This research will determine how policies enacted as a result of the COVID-19 pandemic response have affected both access to overdose prevention and treatment resources, as well as rates of fatal and non-fatal overdoses in the community. The effect of acute changes on COVID-19 related diagnoses, hospitalizations, and deaths on subsequent spikes in fatal and nonfatal overdose, particularly in racial/ethnic and economically distressed communities, will also be examined. Documenting these impacts will provide important insights into the types of health service measures that need to be put in place during future disasters to avoid escalation of drug overdose risk. The study will take place in Rhode Island, a state with the 4th highest COVID-10 diagnosis rate and the 7th highest COVIDassociated mortality rates in the nation (as of May 18th, 2020). In Aim 1, we will determine how policies enacted as part of the state’s COVID-19 pandemic response have influenced both access to and utilization of harm reduction resources (e.g., naloxone) and engagement in substance use treatment, as well as rates of fatal and non-fatal overdoses. In Aim 2, we hypothesize that various measures of COVID-19 disease burden (e.g., diagnosis rates, hospitalizations) will predict subsequent spikes in fatal and non-fatal overdose, and that these spikes will be particularly pronounced in economically distressed and racial/ethnic minority communities. This work will help build an urgently needed evidence base to determine how best to effectively manage the adverse effects of COVID-19 on the overdose epidemic, and to support addiction-related health and social service systems during unanticipated public health crises in the future.
COVID-19大流行与正在进行的药物过量流行病相撞,这是一种公共卫生危机 在过去的二十年中,在美国夺走了75万多人的生命。大流行和相关 政策回应将对有过量用药风险的人们的生命产生持久的影响。而且,直接 大流行对获得过量药物预防和治疗资源的影响以及致命的影响 非致命过量率需要紧急研究。这项研究将决定政策如何作为一个 共同19的大流行反应的结果都影响了预防过量和治疗的机会 社区中的资源以及致命和非致命性过量的发生率。急性变化对 COVID-19相关诊断,住院和随后致命和非致命性峰值的死亡 服用过量,特别是在种族/种族和经济苦恼的社区中,也将被检查。 记录这些影响将为卫生服务措施的类型提供重要的见解 在将来的灾难中需要进行到位,以避免药物过量风险的升级。该研究将接受 位于罗德岛州的位置,该州的诊断率是第四高的州,共同诊断率是第七高的州 全国的死亡率(截至2020年5月18日)。在AIM 1中,我们将确定政策如何 作为该州共同19-19的大流行反应的一部分制定的已影响和利用 减少损害资源(例如纳洛酮)和在药物使用治疗中的参与以及 致命和非致命性过量。在AIM 2中,我们假设Covid-19疾病伯恩的各种度量 (例如,诊断率,住院率)将预测致命和非致命过量的随后峰值,并且 在经济困扰和种族/族裔少数民族中,这些尖峰将特别明显 社区。这项工作将有助于建立急需的证据基础,以确定如何最好地有效 管理Covid-19对过量流行的不良影响,并支持与成瘾有关的健康 未来意料之外的公共卫生危机期间的社会服务系统。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

Magdalena Cerda的其他基金

A comparative evaluation of overdose prevention programs in New York City and Rhode Island
纽约市和罗德岛州药物过量预防计划的比较评估
  • 批准号:
    10629749
    10629749
  • 财政年份:
    2023
  • 资助金额:
    $ 16.85万
    $ 16.85万
  • 项目类别:
Understanding the short- and long-term effects of the COVID-19 pandemic on the overdose crisis
了解 COVID-19 大流行对药物过量危机的短期和长期影响
  • 批准号:
    10739492
    10739492
  • 财政年份:
    2023
  • 资助金额:
    $ 16.85万
    $ 16.85万
  • 项目类别:
Large Data Spatiotemporal Modeling of Optimal Combinations of Interventions to Reduce Opioid Harm in the United States
美国减少阿片类药物危害的最佳干预措施组合的大数据时空建模
  • 批准号:
    10708823
    10708823
  • 财政年份:
    2022
  • 资助金额:
    $ 16.85万
    $ 16.85万
  • 项目类别:
Large Data Spatiotemporal Modeling of Optimal Combinations of Interventions to Reduce Opioid Harm in the United States
美国减少阿片类药物危害的最佳干预措施组合的大数据时空建模
  • 批准号:
    10521949
    10521949
  • 财政年份:
    2022
  • 资助金额:
    $ 16.85万
    $ 16.85万
  • 项目类别:
Examining the synergistic effects of cannabis and prescription opioid policies on chronic pain, opioid prescribing, and opioid overdose
检查大麻和处方阿片类药物政策对慢性疼痛、阿片类药物处方和阿片类药物过量的协同作用
  • 批准号:
    10055772
    10055772
  • 财政年份:
    2019
  • 资助金额:
    $ 16.85万
    $ 16.85万
  • 项目类别:
Reducing Drug-Related Mortality Using Predictive Analytics: A Randomized, Statewide, Community Intervention Trial
使用预测分析降低药物相关死亡率:一项随机、全州范围的社区干预试验
  • 批准号:
    10026087
    10026087
  • 财政年份:
    2019
  • 资助金额:
    $ 16.85万
    $ 16.85万
  • 项目类别:
Examining the synergistic effects of cannabis and prescription opioid policies on chronic pain, opioid prescribing, and opioid overdose
检查大麻和处方阿片类药物政策对慢性疼痛、阿片类药物处方和阿片类药物过量的协同作用
  • 批准号:
    9987897
    9987897
  • 财政年份:
    2019
  • 资助金额:
    $ 16.85万
    $ 16.85万
  • 项目类别:
Reducing Drug-Related Mortality Using Predictive Analytics: A Randomized, Statewide, Community Intervention Trial
使用预测分析降低药物相关死亡率:一项随机、全州范围的社区干预试验
  • 批准号:
    10220922
    10220922
  • 财政年份:
    2019
  • 资助金额:
    $ 16.85万
    $ 16.85万
  • 项目类别:
Reducing Drug-Related Mortality Using Predictive Analytics: A Randomized, Statewide, Community Intervention Trial
使用预测分析降低药物相关死亡率:一项随机、全州范围的社区干预试验
  • 批准号:
    9817054
    9817054
  • 财政年份:
    2019
  • 资助金额:
    $ 16.85万
    $ 16.85万
  • 项目类别:
Examining the Synergistic Effects of Cannabis and Prescription Opioid Policies on Chronic Pain, Opioid Prescribing, and Opioid Overdose
检查大麻和处方阿片类药物政策对慢性疼痛、阿片类药物处方和阿片类药物过量的协同作用
  • 批准号:
    10208128
    10208128
  • 财政年份:
    2019
  • 资助金额:
    $ 16.85万
    $ 16.85万
  • 项目类别:

相似海外基金

AIDS Clinical Trials Group for Research on Therapeutics for HIV and Related Infections
艾滋病毒及相关感染治疗研究艾滋病临床试验小组
  • 批准号:
    10812944
    10812944
  • 财政年份:
    2023
  • 资助金额:
    $ 16.85万
    $ 16.85万
  • 项目类别:
Beta cell dysfunction as an acute and a post acute sequelae of COVID19
β 细胞功能障碍是 COVID19 的急性和急性后遗症
  • 批准号:
    10505064
    10505064
  • 财政年份:
    2022
  • 资助金额:
    $ 16.85万
    $ 16.85万
  • 项目类别:
Beta cell dysfunction as an acute and a post acute sequelae of COVID19
β 细胞功能障碍是 COVID19 的急性和急性后遗症
  • 批准号:
    10674887
    10674887
  • 财政年份:
    2022
  • 资助金额:
    $ 16.85万
    $ 16.85万
  • 项目类别:
Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/
领导和运营中心(LOC)、艾滋病临床试验组(ACTG);
  • 批准号:
    10594377
    10594377
  • 财政年份:
    2022
  • 资助金额:
    $ 16.85万
    $ 16.85万
  • 项目类别:
Increasing representation of black communities in SARS-CoV-2 serosurveys by understanding barriers and motivations for participation
通过了解参与的障碍和动机,增加黑人社区在 SARS-CoV-2 血清调查中的代表性
  • 批准号:
    10843497
    10843497
  • 财政年份:
    2021
  • 资助金额:
    $ 16.85万
    $ 16.85万
  • 项目类别: